Michel Gaudet

697 total citations
21 papers, 573 citations indexed

About

Michel Gaudet is a scholar working on Pulmonary and Respiratory Medicine, Psychiatry and Mental health and Oncology. According to data from OpenAlex, Michel Gaudet has authored 21 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Psychiatry and Mental health and 3 papers in Oncology. Recurrent topics in Michel Gaudet's work include BRCA gene mutations in cancer (2 papers), Medication Adherence and Compliance (2 papers) and Diabetes Treatment and Management (2 papers). Michel Gaudet is often cited by papers focused on BRCA gene mutations in cancer (2 papers), Medication Adherence and Compliance (2 papers) and Diabetes Treatment and Management (2 papers). Michel Gaudet collaborates with scholars based in Canada, France and United States. Michel Gaudet's co-authors include Claude Leray, Jocelyne Moisan, Jean‐Pierre Grégoire, Isabelle Côté, Alain Milot, R Guibert, Antonio Ciampi, Régis Blais, Pierre Pfitzenmeyer and K.H. Weiss and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Journal of Clinical Epidemiology.

In The Last Decade

Michel Gaudet

19 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Gaudet Canada 11 152 119 91 78 70 21 573
Ingebjørg Baksaas Norway 14 37 0.2× 109 0.9× 33 0.4× 53 0.7× 17 0.2× 26 565
Vanessa DeClercq Canada 19 14 0.1× 36 0.3× 59 0.6× 42 0.5× 5 0.1× 37 782
Bernadette Chevalier France 16 16 0.1× 17 0.1× 85 0.9× 134 1.7× 23 0.3× 38 678
Kristina H. Petersen United States 14 10 0.1× 22 0.2× 57 0.6× 5 0.1× 12 0.2× 37 740
Luís Serra‐Majem Spain 12 30 0.2× 27 0.2× 33 0.4× 7 0.1× 2 0.0× 21 693
Iwan Dwiprahasto Indonesia 14 5 0.0× 10 0.1× 57 0.6× 27 0.3× 5 0.1× 68 618
C. Gómez Candela Spain 13 54 0.4× 13 0.1× 22 0.2× 32 0.4× 44 660
Samir M. Khoja Saudi Arabia 10 7 0.0× 7 0.1× 87 1.0× 6 0.1× 5 0.1× 37 665
Sandra López‐Arana Chile 14 71 0.5× 15 0.1× 190 2.1× 5 0.1× 37 754
Rebecca L. Dunn United States 13 4 0.0× 6 0.1× 27 0.3× 28 0.4× 6 0.1× 30 769

Countries citing papers authored by Michel Gaudet

Since Specialization
Citations

This map shows the geographic impact of Michel Gaudet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Gaudet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Gaudet more than expected).

Fields of papers citing papers by Michel Gaudet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Gaudet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Gaudet. The network helps show where Michel Gaudet may publish in the future.

Co-authorship network of co-authors of Michel Gaudet

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Gaudet. A scholar is included among the top collaborators of Michel Gaudet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Gaudet. Michel Gaudet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Robins, Stéphanie, et al.. (2024). The Impact of COVID-19 Health Measures on Adults With Multiple Chemical Sensitivity: Cross-Sectional Study. JMIR Formative Research. 8. e48434–e48434.
2.
Gaudet, Michel, et al.. (2018). Cryotherapy of Airway Stenosis after Lung Transplant. The Journal of Heart and Lung Transplantation. 37(4). S449–S450. 1 indexed citations
3.
Gaudet, Michel, et al.. (2013). Crash rates of quebec drivers with medical conditions.. PubMed. 57. 57–66. 12 indexed citations
4.
Weiss, K.H., et al.. (2011). Impact of a Multipronged Education Strategy on Antibiotic Prescribing in Quebec, Canada. Clinical Infectious Diseases. 53(5). 433–439. 41 indexed citations
6.
Dorval, Michel, et al.. (2007). Effect of the Women's Health Initiative Study Publication on Hormone Replacement Therapy Use among Women Who Have Undergone BRCA1/2 Testing. Cancer Epidemiology Biomarkers & Prevention. 16(1). 157–160. 4 indexed citations
7.
Moisan, Jocelyne, Jean‐Pierre Grégoire, Michel Gaudet, & Dan M. Cooper. (2005). Exploring the risk of diabetes mellitus and dyslipidemia among ambulatory users of atypical antipsychotics: a population‐based comparison of risperidone and olanzapine. Pharmacoepidemiology and Drug Safety. 14(6). 427–436. 18 indexed citations
8.
Cooper, Dan M., Jocelyne Moisan, Michel Gaudet, Belkacem Abdous, & Jean‐Pierre Grégoire. (2005). Ambulatory Use of Olanzapine and Risperidone: A Population-Based Study on Persistence and the Use of Concomitant Therapy in the Treatment of Schizophrenia. The Canadian Journal of Psychiatry. 50(14). 901–908. 27 indexed citations
9.
Dorval, Michel, Elizabeth Maunsell, Michel J. Dugas, et al.. (2005). No Evidence of False Reassurance among Women with an Inconclusive BRCA1/2 Genetic Test Result. Cancer Epidemiology Biomarkers & Prevention. 14(12). 2862–2867. 40 indexed citations
10.
Moisan, Jocelyne, et al.. (2004). What Do Québec Children Eat During Their First Six Months?. Canadian Journal of Dietetic Practice and Research. 65(3). 106–113. 7 indexed citations
11.
Moisan, Jocelyne, et al.. (2002). Non-Compliance with Drug Treatment and Reading Difficulties with Regard to Prescription Labelling among Seniors. Gerontology. 48(1). 44–51. 53 indexed citations
12.
Grégoire, Jean‐Pierre, Jocelyne Moisan, R Guibert, et al.. (2002). Determinants of discontinuation of new courses of antihypertensive medications. Journal of Clinical Epidemiology. 55(7). 728–735. 62 indexed citations
13.
Grégoire, Jean‐Pierre, Jocelyne Moisan, Isabelle Chabot, & Michel Gaudet. (2000). Appropriateness of Omeprazole Prescribing in Quebec’s Senior Population. SHILAP Revista de lepidopterología. 14(8). 676–680. 5 indexed citations
14.
Moisan, Jocelyne, Renée Bourbonnais, Chantal Brisson, et al.. (1999). Job strain and psychotropic drug use among white-collar workers. Work & Stress. 13(4). 289–298. 43 indexed citations
15.
Moisan, Jocelyne, et al.. (1999). Preferred hydroxymethylglutaryl–coenzyme A reductase inhibitors: Treatment-modification program and outcomes. American Journal of Health-System Pharmacy. 56(14). 1437–1441. 7 indexed citations
16.
Pfitzenmeyer, Pierre, et al.. (1994). Thiamine status of elderly patients with cardiac failure including the effects of supplementation.. PubMed. 64(2). 113–8. 33 indexed citations
17.
Pfitzenmeyer, Pierre, et al.. (1993). Lung Function in Advanced Age: Study of Ambulatory Subjects Aged over 75 Years. Gerontology. 39(5). 267–275. 9 indexed citations
18.
Pfitzenmeyer, Pierre, et al.. (1992). Évaluation des statuts vitaminiques en B1, B6, C et folates dans une population hospitalisée en service de Médecine Interne gériatrique. La Revue de Médecine Interne. 13(7). S541–S541. 1 indexed citations
19.
Pfitzenmeyer, Pierre, et al.. (1991). Pneumopathie du Nilutamide : 3 cas. La Revue de Médecine Interne. 12(3). S230–S230. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026